CLU and hepatocellular carcinoma: In vitro studies conducted in breast, renal, nasopharyngeal, and hepatocellular cancer cell lines found that MMP-9 and MMP-2 expression is reduced following CLU silencing, concomitantly with a decrease in cell motility and invasion [155,156,157,158].